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The innate immune response plays a pivotal role during human cytomegalovirus (HCMV) 25 
primary infection. Indeed, HCMV infection of primary fibroblasts rapidly triggers strong induction of 26 
type I interferons (IFN-I) accompanied by proinflammatory cytokine release. Here, we show that 27 
primary human foreskin fibroblasts (HFFs) infected with a mutant HCMV TB40/E strain unable to 28 
express UL83-encoded pp65 (v65Stop) produce significantly higher IFN-β levels than HFFs infected 29 
with the wild-type TB40/E strain or the pp65 revertant (v65Rev), suggesting that the tegument protein 30 
pp65 may dampen IFN- production. To clarify the mechanisms through which pp65 inhibits IFN-β 31 
production, we analyzed the activation of the cGAS/STING/IRF3 axis in HFFs infected with either 32 
wild-type, v65Rev or the pp65-deficient mutant v65Stop. We found that pp65 selectively binds to 33 
cGAS and prevents its interaction with STING, thus inactivating the signaling pathway through the 34 
cGAS/STING/IRF3 axis. Consistently, addition of exogenous cGAMP to v65Rev infected cells 35 
triggered the production of IFN-β levels similar to those observed with v65Stop infected cells 36 
confirming that pp65 inactivation of IFN-β production occurs at the cGAS level. Notably, within the 37 
first 24 hours of HCMV infection, STING undergoes proteasome degradation independent of the 38 
presence or absence of pp65. Collectively, our data provide mechanistic insights into the interplay 39 






















Primary human foreskin fibroblasts (HFFs) produce type I IFN (IFN-I) when infected with 49 
HCMV. However, we observed significantly higher IFN- levels when HFFs were infected with 50 
HCMV unable to express UL83-encoded pp65 (v65Stop), suggesting that pp65 (pUL83) may 51 
constitute a viral evasion factor. This study demonstrates that HCMV tegument protein pp65 inhibits 52 
IFN-β production by binding and inactivating cGAS early during infection. In addition, this inhibitory 53 
activity specifically targets cGAS since it can be bypassed via the addition of exogenous cGAMP, even 54 
in presence of pp65. Notably, STING proteasome-mediated degradation was observed in both the 55 
presence and absence of pp65. Collectively, our data underscore the important role of tegument protein 56 





























Human cytomegalovirus (HCMV), a member of the Herpesviridae family, is a widespread 73 
pathogen with a seroprevalence that ranges from 50% to 90% depending on geographical area and 74 
socioeconomic factors. The virus establishes a lifelong infection that is asymptomatic in the 75 
immunocompetent host despite occurrence of periodic reactivation and subsequent virus-shedding 76 
episodes. However, reactivation in the immunocompromised host or infection of the immunologically 77 
naïve fetus in utero can cause significant morbidity and mortality. Indeed, congenital HCMV infection 78 
can lead to abortion or dramatic disabilities, such as deafness and mental retardation (1, 2).  79 
 Pathogen recognition receptors (PRRs) detect viral components, such as viral nucleic acid, and 80 
subsequently lead to the induction of type I interferons (IFN-I), including IFN-α/β, which, in turn, 81 
triggers the expression of numerous IFN-stimulated genes (ISGs) (3). PRRs may be located either on 82 
the cell membrane, e.g. Toll-like receptors, or in the cytosol and in the nucleus; the latter group 83 
includes retinoic acid-inducible gene I (RIG-I)-like receptors, nucleotide-binding oligomerization 84 
domain (NOD)-like receptors, and several proteins involved in the DNA damage response (4–7). 85 
Intracellular dsDNA receptors, such as DNA-dependent activator of interferon regulatory factors (DAI; 86 
also known as ZBP1) (8, 9) and IFN--inducible protein 16 (IFI16), have been identified to recognize 87 
HCMV components (10–16). More recent studies have demonstrated that the dsDNA receptor - cyclic 88 
GMP/AMP (cGAMP) synthase (cGAS) - is activated upon HCMV DNA binding and synthesizes the 89 
second messenger 2’-5’/3’-5’ GMP/AMP (cGAMP) (17–21). Subsequently, cGAMP binds to the ER 90 
transmembrane adaptor protein stimulator of IFN genes (STING) and triggers its translocation from the 91 
ER to perinuclear punctate structures in order to induce IFN-I induction via TANK-binding kinase 92 
(TBK1) and IFN regulatory factor 3 (IRF3) (13, 22, 23).  93 
 On the opposing side, viruses have adopted various strategies to evade host innate immune 94 
responses and to establish persistent infection (14, 24–26). In particular, herpesviruses have evolved 95 
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strategies that target distinct steps in the signaling of IFN-I production (27–29). Su and Zheng (30) 96 
showed that HSV-1 tegument protein UL41 was involved in counteracting the cGAS/STING-mediated 97 
DNA-sensing pathway. HSV-1 ICP0, a viral E3 ubiquitin ligase, was shown to promote proteasome-98 
dependent degradation of the DNA sensor IFI16 (31, 32). Another HSV-1 immediate early gene 99 
product, ICP27, has been demonstrated to antagonize IFN-I signaling by targeting the TBK1-activated 100 
STING signalosome, followed by accumulation of IRF3 into the nucleus (33), or by downregulating 101 
STAT-1 phosphorylation and accumulation in the nucleus (34). Finally, VP16, an abundant 65-kDa 102 
HSV-1 virion phosphoprotein, has been shown to inhibit IRF3 from recruiting its coactivator CREB-103 
binding protein, thereby blocking its transactivation activity (35). With respect to HCMV, previous 104 
studies by Abate at al. (36) demonstrated that during virus infection pp65 prevented IRF3 activation in 105 
the IFN-I response by inhibiting its nuclear accumulation associated with a reduced IRF3 106 
phosphorylation state. Moreover, pp65 has been shown to bind directly to the nuclear DNA sensor 107 
IFI16, which impairs its DNA-dependent oligomerization and triggers its nuclear delocalization 108 
followed by inhibition of subsequent immune signals (26, 37). Consistent with these results, another 109 
HCMV tegument protein, pUL82/pp71, was recently identified as a negative regulator of the STING-110 
dependent antiviral response, impairing its cellular trafficking and formation of the TBK1/IRF3 111 
complex (29).  112 
Although these studies demonstrate that tegument proteins can down-regulate type I interferons 113 
production during HCMV infection, they currently offer only limited insight into the mechanisms these 114 
viral proteins rely on to counteract the cGAS/STING/IRF3 axis leading to reduced IFN-I production. 115 
Thus, to fill this gap, we sought to compare the IFN-β response in HFFs upon infection with a pp65 116 
mutant HCMV, that is unable to express UL83-encoded pp65 (v65Stop), with that observed with the 117 
wild-type TB40/E strain (wild-type) or the pp65 revertant (v65Rev) viruses that express normal levels 118 
of pp65.  119 
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We show that primary HFFs infected with HCMV v65Stop produce significantly higher IFN-β 120 
levels than HFFs infected with HCMV wild-type or v65Rev, suggesting that the tegument protein pp65 121 
impairs IFN-β production. Furthermore, when we analyzed the mode of action, we found that pp65 122 
binds to cGAS and inhibits the release of a biologically active cGAMP, preventing its interaction with 123 
STING, and thus interfering with the cGAS/STING signaling pathway. The finding that the response to 124 
exogenous cGAMP is not affected by pp65 confirms that cGAS is the key target of pp65. Finally, we 125 
demonstrate that STING undergoes rapid degradation early during infection independent of pp65. 126 
Altogether, this work defines a previously unrecognized mechanism underlying HCMV evasion, i.e. 127 
cGAS inactivation, which assigns a critical role to pp65 in determining the outcome of host defense 128 
and viral pathogenesis.  129 
 130 
RESULTS 131 
The HCMV tegument protein pp65 inhibits IFN- induction early during infection. It has been 132 
demonstrated that infection of HFFs with HCMV induces the production of IFN-I through activation of 133 
the cGAS/STING/IRF3 signaling pathway (13, 21, 26, 29). On the opposing side, the HCMV tegument 134 
protein pp65 has been shown to inhibit IFN-I expression by preventing IRF3 activation or by inhibiting 135 
IFI16-mediated DNA sensing for immune evasion (36), suggesting that the cGAS/STING/IRF3 and/or 136 
IFI16-signaling pathways become blocked. Here we sought to determine whether the 137 
immunosuppressive function of pp65 could also be extended to other components of these signaling 138 
pathways, i.e. cGAS and STING, thereby interfering with the activation of IFN-I production. For this 139 
purpose, we compared IFN-β induction in HFFs infected with a pp65 mutant virus unable to express 140 
UL83-encoded pp65 (v65Stop), the TB40/E wild-type virus or the revertant (v65Rev) virus (37, 38). 141 
To this end, HFFs were mock-infected, infected with wild-type, v65Rev, or infected with v65Stop at an 142 
MOI of 1 and total RNA, harvested at 6 h post infection (hpi), was analyzed by RT-qPCR. As shown in 143 
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Fig. 1A, the IFN- mRNA levels observed with v65Stop were ~2.7-fold higher than those observed 144 
with wild-type- or v65Rev- virus-infected cells, suggesting that HCMV pp65 impairs IFN-β 145 
production. Interestingly, HFF treatment with the synthetic dsRNA poly(I:C), which mimics RNA 146 
virus infection and induces antiviral immune responses by promoting the production of both type I 147 
IFNs (39), induced IFN-β levels similar to those observed in cells infected with v65Stop.  148 
To provide further evidence supporting the physiological relevance of pp65 in the regulation of 149 
IFN- production, HFFs, transduced with an adenoviral-derived vector constitutively expressing pp65 150 
protein (AdVpp65) or with control vector AdVLacZ at an MOI of 50 for 24 h, were infected with 151 
v65Stop for 6 h (MOI of 1). RT-qPCR analysis revealed that IFN-β mRNA transcription was 152 
significantly decreased in AdVpp65-infected cells compared with AdVLacZ-infected cells (~90% 153 
reduction) (Fig. 1B). Taken together, these results support the immunosuppressive role of pp65 in 154 
down-regulating IFN-β production in HCMV-infected cells and its contribution to innate immune 155 
response evasion. 156 
Next, we wanted to verify whether higher levels of IFN-β mRNA in v65Stop-infected HFFs 157 
correlated with an increase in the production of biologically active IFN-β protein. To this purpose, 158 
supernatants from HFFs infected with wild-type, v65Rev, and v65Stop viruses were harvested at 24 hpi 159 
and assessed by ELISA for IFN- production. In parallel, HFFs were stimulated with poly(I:C). As 160 
shown in Fig. 1C, consistent with the results obtained with RT-qPCR, the levels of IFN- secreted at 161 
24 hpi were significantly higher when cells were infected with the v65Stop virus or stimulated with 162 
poly(I:C), compared to those observed with HFFs infected with wild-type or v65Rev viruses, 163 
confirming that in the presence of HCMV pp65 the transduction pathway leading to IFN- production 164 
is impaired (Fig. 1C). 165 
HCMV pp65 dampens IFN-β production by inactivating the cGAS/STING/IRF3 axis. HCMV 166 
infection can be detected by multiple innate sensing pathways, including TLR2 and TLR9, in diverse 167 
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cell types (14, 40, 41). In addition to TLRs, the HCMV dsDNA genome directly engages cytosolic or 168 
nuclear DNA-sensing pathways, including DAI/ZBP1 (42), AIM2 (43, 44), the cGAS/STING/IRF3 169 
axis, and IFI16, respectively (13, 20, 21, 33, 39, 45–47). 170 
To better understand how pp65 dampens IFN- production during HCMV infection, we 171 
generated knockout (KO) gene variants in HFFs through CRISPR-Cas 9 technology. Primary cell lines 172 
carrying mutations in genes encoding cGAS (cGAS KO), STING (STING KO), and IFI16 (IFI16 KO) 173 
were generated based on three different guide RNAs. Verification of genetic KO was carried out by 174 
RT-qPCR, Western blot, and TIDE (Tracking of Indels by DEcomposition) analysis (48). As shown in 175 
Fig. 2, expression of cGAS, STING, and IFI16 genes was efficiently abrogated at both the mRNA 176 
(panel A) and protein (panel B) levels. Moreover, a TIDE analysis of the STING and IFI16 knockdown 177 
populations shows an overall knockdown efficiency of 87% (Fig. 2C) and 82% (Fig. 2D) respectively. 178 
This shows that in above 80% of the cells carry an indel (insertion or deletion) in the targeted gene, that 179 
leads to a frameshift in the reading frame, rendering the gene not-functional. Unfortunately, due to a 180 
technical limitation of the TIDE analysis, we have been so far unable to confirm cGAS knockout in 181 
CRISPR/Cas9 expressors. This limitation is likely due to the high number of repeats upstream and 182 
downstream the region of the cGAS gene (MB21D1) targeted by the gRNA, which makes it nearly 183 
impossible to generate a clean target side spanning PCR amplicon. Furthermore, this region displays an 184 
unusually high GC content, which, coupled with the high repeat number, is likely responsible for the 185 
low signal-to-noise ratio and the ensuing early sequencing termination that has hampered our attempts. 186 
However, the Western Blot and qPCR data clearly shows that the majority of the cells is silenced for 187 
cGAS (Fig. 2A, B). 188 
We therefore sought to determine whether these KO cell lines exhibited a dependence on these 189 
three genes for HCMV-induced IFN-β expression. Consistent with the above results (Fig. 1), elevated 190 
IFN-β mRNA induction was observed at 6 hpi in normal HFFs infected with v65Stop, whereas 191 
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infection with wild-type virus or v65Rev virus triggered lower, albeit significant levels of IFN-β 192 
mRNA expression. By contrast, induction of IFN-β mRNA expression was completely abolished in 193 
HFFs lacking cGAS or STING independent of the type of virus used for infection. Interestingly, 194 
although dramatically decreased, a minor residual of IFN-β induction was still observed in IFI16 KO 195 
cells (Fig. 3A).  196 
Taken together, these results confirm that cGAS and STING, and to a lesser extent IFI16, are 197 
required for early immune activation by HCMV infection, consistent with the results reported by other 198 
investigators (21, 49). 199 
Next, to address whether disruption of the IFI16/cGAS/STING pathway affected the secretion 200 
of IFN-β, we performed an ELISA specific for IFN-β using supernatants obtained from HFFs 201 
permanently depleted for IFI16, cGAS, or STING, respectively, and then infected with wild-type, 202 
v65Rev or v65Stop for 24 h. A significant decrease in IFN-β production was observed in cells depleted 203 
for cGAS and STING and then infected with wild-type, v65Rev or v65Stop viruses (Fig. 3B), thus 204 
confirming that these proteins are necessary for the effective production of IFN-β during HCMV 205 
infection, independent of the presence of pp65. In agreement with the RT-qPCR results, a residual 206 
induction of IFN-β release was observed in HCMV-infected IFI16-deficient compared with HFFs void 207 
of cGAS and STING. Altogether, these results indicate that cGAS and STING, and to a lesser extent 208 
IFI16, are essential to mount abundant IFN-β responses to HCMV. 209 
To exclude potential off-target effects of the cGAS-, STING-, and IFI16-directed CRISPR 210 
knockout, we assessed innate immune responses to the synthetic dsRNA poly(I:C), known to trigger 211 
RIG-I activation (39). In this case, both IFN-β expression and release were not affected by knocking 212 
out the above genes, thereby ruling out non-specific off-target effects (Fig. 3C, D).   213 
pp65 inhibits enzymatic activity of cGAS. To define the relative role of cGAS and pp65 interplay in 214 
innate sensing, we examined the production of cGAMP - the product of cGAS - in HFFs upon infection 215 
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with wild-type, v65Rev or v65Stop viruses. cGAMP activity was measured in cell extracts using a 216 
modified bioassay based on the original method of Orzalli et al. (50) that analyses the induction of IFN-217 
β transcripts, as a marker of cGAMP activity, in permeabilized secondary reporter cells (HFFs) at 24 218 
hpi. As shown in Fig. 4A, an increase in cGAMP activity was observed in HCMV-infected HFFs. 219 
However, the lack of pp65 in cells infected with v65Stop resulted in more robust cGAMP activity 220 
compared with wild-type and v65Rev-infected cells, indicating that interaction of pp65 with cGAS 221 
impairs cGAMP production. 222 
To understand whether pp65 is able to modulate cGAMP activity by itself during viral 223 
replication, HFFs transfected with an HaloTag® fusion plasmid expressing the full-length pp65 224 
(indicated as pp65 Halo-WT) were infected with HCMV v65Stop. At 6 hpi, the induction of IFN-β 225 
transcripts in permeabilized secondary reporter cells (HFFs) was measured (Fig. 4B). As expected, 226 
infection with v65Stop exhibited significantly higher cGAMP activity compared with mock-infected 227 
HFFs. Of note, the ability of v65Stop to induce IFN-β was almost completely ablated (~80%) after the 228 
expression of pp65 Halo-WT, further confirming that pp65 is crucial for cGAS activity suppression.  229 
Next, we sought to determine whether the suppression exerted by pp65 was specific for HCMV 230 
DNA or could be extended to other cyclic di-nucleotides that are sensed by cGAS. Interestingly, a 231 
similar pattern of cGAMP activity modulation was observed following transfection of HFFs with the 232 
dsDNA synthetic analog poly(dA-dT), indicating that pp65 acts directly on cGAS activity, 233 
independently of the type of viral DNA, whether it is viral or synthetic (Fig. 4C). 234 
As the DNA sensor IFI16 has been recently reported to cooperate with cGAS for DNA sensing 235 
in fibroblasts (50), human keratinocytes (46), and human macrophages (39), and to modulate STING 236 
activation in keratinocytes (46), we next tested whether IFI16 would be able to influence cGAS activity 237 
for the production of the second messenger cGAMP. To this purpose, cGAS KO, STING KO, and 238 
IFI16 KO HFFs (39) were infected with wild-type, v65Rev or v65Stop viruses, and whole-cell extracts 239 
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were harvested at 24 hpi and analyzed for the presence of cGAMP activity. As shown in Fig. 3D, 240 
depletion of cGAS, STING, and IFI16 resulted in a significant reduction in IFN-β production, 241 
confirming the cooperation of cGAS and IFI16 in cGAMP production upon HCMV infection. 242 
Finally, to understand if the inhibitory activity of pp65 is limited to cGAS or could be extended 243 
to downstream components of the cGAS/STING/IRF3 axis, we tested whether pp65 affects the 244 
activation of STING by exogenous addition of cGAMP (39, 46). To this purpose, HFFs were 245 
transfected with synthetic 2’3’-cGAMP or with the linearized 2’3’-cGAMP control, as described by 246 
Jonsson et al. (39), Almine et al. (46), and the IFN-β gene expression response over time was 247 
quantified. As shown in Fig. 4E, the delivery of synthetic cGAMP induced the expression of IFN-β 248 
mRNA, peaking at 24 h post transfection (hpt), even in presence of pp65 Halo-WT, indicating that 249 
pp65 inhibitory activity is limited to cGAS and can be bypassed by direct addition of 2’3’-cGAMP. As 250 
expected, HFFs transfected with 2’3’-cGAMP control exhibited a severely blunted response.  251 
pp65 selectively interacts with cGAS. To investigate whether cGAS localization could be regulated 252 
during HCMV infection, HFFs were mock-infected or infected with wild-type, v65Rev or v65Stop 253 
viruses (MOI of 1). The intracellular localization of pp65 and cGAS was assessed by confocal 254 
microscopy at 2 hpi. In both mock- and HCMV-infected cells cGAS was localized in the cytoplasm, as 255 
previously reported (27, 45, 51, 52). Interestingly, cGAS-defined puncta also occurred in the nucleus 256 
(Fig. 5A), in accordance with Orzalli et al. (50), where they colocalized with pp65. Analysis of 3D 257 
reconstructions created using the confocal Z stacks to enhance the colocalization analysis confirmed 258 
this observation (Fig. 5A, far right pictures). Because pp65 and a subset of cGAS showed 259 
colocalization, we hypothesized that they could form a heterocomplex. To learn more about the basis of 260 
a pp65-cGAS interaction, we attempted to monitor the pp65-cGAS interaction during HCMV infection 261 
in situ using a proximity ligation assay (PLA). PLA allows the detection of adjacent proteins through 262 
the use of antibodies which recognize two proteins located within a maximum distance of 40 nm to 263 
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each other (37). Mock-, wild-type, v65Rev- and v65Stop-infected HFFs (MOI of 1) were fixed at 2 hpi, 264 
stained with anti-pp65 and anti-cGAS antibodies, and their interaction analyzed by PLA. As shown in 265 
Fig. 5B, cGAS and pp65 were mostly found in close proximity early on during HCMV infection with 266 
wild-type and v65Rev. 267 
Given the novelty of these results, pp65-cGAS interaction was also confirmed by the 268 
immunoprecipitation (IP) of pp65 from lysates of infected cells at 2 hpi with an anti-pp65 monoclonal 269 
antibody (MAb), or with an unrelated MAb of the same isotype as negative control (CTRL). 270 
Immunoprecipitates were then analyzed by immunoblotting with antibodies directed against cGAS or 271 
pp65. The presence of pp65 and cGAS in all protein extracts was monitored by the analysis of Input 272 
control samples (non-immunoprecipitated whole-cell extracts) (Fig. 5C). As shown in Fig. 5C (left and 273 
middle panel), a band corresponding to cGAS was detectable in precipitates of wild-type and v65Rev-274 
infected cell lysates when pp65 was precipitated with an antibody against virus pp65. The specificity of 275 
this interaction was verified by the observation that no signal was detected in immunoprecipitates 276 
obtained from v65Stop infected cell lysates (Fig. 4C, right panel) or in samples with CTRL antibody 277 
(Fig. 5C). Moreover, in coimmunoprecipitation experiments with STING, no interaction with pp65 278 
could be observed (Fig. 5C), suggesting that pp65 interacts with cGAS, but not with STING during 279 
HCMV infection.  280 
It has been demonstrated by our and other groups that pp65 binds to HCMV DNA (26, 37). 281 
DNA-binding proteins can associate during immunoprecipitation due to their adjacent binding on DNA 282 
rather than due to protein-protein interactions. To determine whether nucleic acid is required for the 283 
pp65/cGAS association, pp65 was immunoprecipitated from HCMV-infected cell lysates using anti-284 
pp65 MAb in the presence or absence of the DNA-degrading enzyme benzonase, and then probed by 285 
Western blot analysis using an anti-cGAS antibody. cGAS was detected in immunoprecipitates from 286 
infected lysates in both the absence and presence of benzonase, whereas no migrating bands 287 
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corresponding to cGAS protein were detected in the absence of primary antibodies (Fig. 5D, left panel). 288 
The activity of benzonase on nucleic acid was confirmed when the cell lysates analyzed in Fig. 4D 289 
were examined on an ethidium bromide-stained agarose gel (Fig. 5D, right panel).  290 
pp65 displays a bipartite structure, with a conserved N-terminal domain (~386 residues), a 291 
divergent linker region, and a conserved C terminus (CTD, ~90 residues) (26). Thus, to learn more 292 
about the basis of the pp65/cGAS interaction, we employed HaloTag® technology to generate 293 
HaloTag® fusion plasmids expressing the full-length pp65 (indicated as pp65 Halo-WT), the N-294 
terminal domain (pp65 Halo-ΔC, deletion of residues 371-561), or the C-terminus (pp65 Halo-ΔN, 295 
deletion of residues 1-414). HFFs were transfected with the above described constructs, and 72 h later, 296 
IP was carried out using a MAb recognizing HaloTag, or control antibodies. Immunoprecipitated 297 
proteins were examined by Western blot using antibodies recognizing cGAS. As depicted in Fig. 4E, 298 
constructs harboring the N-terminal residues 1-414 could efficiently bind cGAS (Fig. 5E, lanes 1 and 299 
3), while lack of this domain (lane 2) abolished cGAS binding. We can therefore conclude that the N-300 
terminal domain is necessary and sufficient for pp65 interaction with cGAS.  301 
pp65 does not interfere with STING proteasome degradation during HCMV infection. Recent 302 
work by Fu et al. (29) has shown that HCMV tegument protein pUL82/pp71 binds to and inhibits 303 
STING-mediated signaling to evade innate antiviral immunity. To investigate whether pp65 could also 304 
interfere with STING – the down-stream component of cGAS in the signaling pathway leading to IFN-305 
β production – we examined the levels of STING expression at different hpi in mock-infected HFFs, or 306 
upon v65Rev- or v65Stop-infection (MOI of 1). As shown in Fig. 6A, cells infected with wild-type, 307 
v65Rev and v65Stop viruses displayed comparable levels of cGAS up to 24 hpi that were similar to 308 
those in mock HFFs. By contrast, infection with both v65Rev and v65Stop induced degradation of 309 
STING within 24 hpi, suggesting that STING expression is independent of the presence of pp65. 310 
Moreover, the finding that STING is activated in the first hours post transfection and then disappears 311 
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within 24 h in cells transfected with the synthetic dsDNA poly(dA-dT) (Fig. 6B) suggests that DNA 312 
sensing, independent of pp65, is responsible for STING disappearance (29, 53–56).  313 
We hypothesized that disappearance of STING before 24 hpi could be caused by a rapid 314 
proteasomal degradation. To test this hypothesis, the effect of proteasomal inhibition on STING protein 315 
levels was assessed early during HCMV infection. HFFs were pretreated with the proteasome inhibitor 316 
MG132 for 30 min and then infected with either wild-type, v65Rev or v65Stop for 6 or 24 h. As shown 317 
in Fig 6C, STING levels were rescued by MG132, in contrast to solvent-treated cells (DMSO), 318 
indicating that STING undergoes proteasomal degradation early during HCMV infection.  319 
To test whether ubiquitination is responsible for proteasomal degradation of STING as 320 
previously reported (57), HFFs were infected with wild-type, v65Rev or v65Stop viruses (MOI of 1) 321 
and ubiquitinated proteins immunoprecipitated from cell lysates by anti-ubiquitin antibodies followed 322 
by detection of STING with specific anti-STING antibodies. As shown in Fig. 6D, upper panel, STING 323 
was immunoprecipitated by anti-ubiquitin antibodies from HCMV infected cell lysates, suggesting that 324 
HCMV infection induces ubiquitination and thus degradation of STING. K48-linked ubiquitination is 325 
normally associated with proteasome-mediated protein degradation (57). By using a specific antibody 326 
for immunoprecipitation and detection of STING in precipitates of HCMV infected cells, we confirm 327 
the ubiquitination of STING on K48-linked residues that is apparently induced by HCMV infection 328 
(Fig. 6E).  329 
 330 
DISCUSSION 331 
Viral DNA is recognized by various PRRs including DAI/ZBP1 (42), AIM2 (43, 44), IFI16, 332 
and cGAS (13, 20, 21, 33, 39, 45–47). cGAS HCMV DNA sensing during the early phase of infection 333 
that leads to the stimulation of the STING/TBK1/IRF3 signaling pathway followed by IFN production. 334 
The IFN response antagonizes virus infection via the repression of viral replication, elimination of 335 
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virus-infected cells, and activation of adaptive immune responses (16, 20, 21, 52, 58, 59). On the 336 
opposing side are diverse immune evasion strategies that viruses, including herpesviruses, have 337 
evolved in order to inhibit the activation of PRRs, such as IFI16 and cGAS, and their down-stream 338 
signaling cascades (60–64).  339 
Although data are available on the activation of IFN production by HCMV, the mechanisms 340 
HCMV relies on to counteract the cGAS signaling pathway are only partially defined. In order to fill 341 
this gap, here we took advantage of three HCMV viruses: the wild-type TB40/E and the v65Rev, both 342 
displaying intact pp65 expression capacity, and v65Stop, unable to express pp65 (38). Our data 343 
demonstrate, for the first time, that the HCMV tegument protein pp65 directly binds and inhibits cGAS 344 
enzymatic activity leading to down-regulation of IFN-β production (Fig. 7). The interaction of pp65 345 
with cGAS required the presence of the N-terminal domain of pp65, whereas it appeared to be 346 
independent of viral DNA, since the digestion of viral DNA by benzonase did not prevent protein 347 
interaction, as shown by immunoprecipitation experiments. Consistent with this, addition of exogenous 348 
cGAMP to v65Rev infected cells triggered the production of IFN levels similar to those observed with 349 
v65Stop infected cells, confirming that pp65 inactivation of IFN-β production occurs at the cGAS 350 
level. Thus, the functional relevance of the inhibitory activity of viral pp65 against cGAS can be 351 
inferred by the observation that infection with a mutant virus that is unable to express pp65 results in a 352 
significant increase in cGAS activity accompanied by a significant increase in IFN production.  353 
Recent studies demonstrate that IFI16 and cGAS cooperate in the activation of STING during 354 
the response to exogenous DNA sensing in human keratinocytes (46). In addition, it has been 355 
demonstrated that IFI16 is required for early DNA sensing in human macrophages by promoting 356 
cGAMP production (39). However, recent findings by Stetson’s group (49) demonstrated that IFI16 is 357 
not essential for the IFN response to human cytomegalovirus infection. Collectively, these results 358 
indicate that the role of IFI16 in the IFN pathway is still a matter of debate. When we infected IFI16-359 
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deficient HFFs, in an attempt to verify whether IFI16 also participates in the modulation of the IFN-β 360 
response to HCMV, a residual IFN-β production was observed, compared to HFFs depleted of STING 361 
and cGAS, suggesting that in human fibroblasts IFI16 is less involved in the signaling transduction 362 
pathway leading to IFN production to HCMV. Partially consistent with our results, Paijo et al. (21) 363 
demonstrated that HCMV- treated cGAS- or STING-deficient THP-1 monocytes exhibit significantly 364 
impaired IFN- production. In contrast, IFI16-deficient THP-1 monocytes infected with HCMV 365 
mounted a robust IFN- response that was moderately enhanced compared with that of wild-type THP-366 
1 cells. All these discrepancies might be explained by the different methods used to ablate IFI16 (i.e., 367 
CRISPR/Cas 9, siRNA, shRNA mediated IFI16 knock-down), by the different viruses and synthetic 368 
DNA employed to stimulate the IFN-I response, and, finally, by the different target cell types employed 369 
(i.e., HFFs, keratinocytes, monocytes, and plasmacytoid dendritic cells).  370 
 Having demonstrated that HCMV pp65 inhibits cGAS activation, next we investigated whether 371 
pp65 could also inactivate STING, the downstream partner of cGAS. Recently, Fu et al. (29) 372 
demonstrated that another HCMV tegument protein, namely pUL82/pp71, binds to and inhibits 373 
STING-mediated signaling leading to viral innate immune evasion. Our results showed that pp65 does 374 
not bind to STING and that regulation of its activity is independent of pp65, as its degradation is 375 
observed within 24 hpi both in the presence or absence of the pp65 protein. This deduction was 376 
generated from the following observations: i) STING degradation is observed upon infection with wild-377 
type, v65Rev or v65Stop: ii) immunoprecipitation experiments showed that pp65 doesn’t bind to 378 
STING; iii) STING degradation is also observed in the presence of unrelated dsDNA, such as synthetic 379 
poly(dA-dT); and iv) it is not modulated by pp65. In addition, in the present study we report that 380 
STING undergoes ubiquitination followed by degradation in HFFs infected with wild-type, v65Rev or 381 
v65Stop within 6 h of infection. The following two findings led us to this conclusion: first, 382 
pretreatment with MG132, a proteasome inhibitor, prevented STING degradation; second, STING was 383 
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ubiquitinated at Lys48, a marker of degradation by ubiquitination. Our results are consistent with 384 
previous studies that delineate the following model of STING activation and downstream signaling 385 
(Fig. 7): intracellular dsDNA induces autophagy and the trafficking of STING/TBK1 through the Golgi 386 
to endosomal compartments that harbor members of the IRF and NF-kB family. These transcription 387 
factors become activated and numerous immune-related genes are induced such as type I IFN and a 388 
variety of cytokines and chemokines. STING is then degraded and the signaling process halted. These 389 
events ensure the transient production of host defense genes required for direct antimicrobial effects as 390 
well as stimulating the adaptive immune response. Eventual suppression of STING function also 391 
ensures that the chronic production of cytokines is prevented, thus avoiding the consequences of 392 
inflammatory disease. 393 
 In conclusion, our data identify a previously unknown role of pp65 in down-regulating the 394 
cGAS/STING/IRF3 axis and thus IFN-β production (see proposed model in Fig. 7). The finding that 395 
HCMV, by means of its tegument proteins, i.e. pp65 and pUL82/pp71 interferes with the activity of all 396 
the components of this signaling pathway (i.e. cGAS, STING, and IRF3) in order to evade the IFN 397 
response underlines the relevance of the IFN system in blocking virus replication. Therefore, further 398 
delineation of the mechanisms through which HCMV inhibits cGAS/STING/IRF3 signaling will not 399 
only help our comprehension of this pathway, but may also facilitate the development of therapeutics 400 
aimed at ameliorating the diseases in which this pathway is altered.  401 
 402 
MATERIALS AND METHODS 403 
Cells and viruses. Primary human foreskin fibroblasts (HFFs, ATCC SCRC-1041™), and human 404 
embryo kidney 293 cells (HEK 293) (Microbix Biosystems Inc.) were cultured in Dulbecco’s modified 405 
Eagle’s medium (DMEM) (Sigma-Aldrich) supplemented with 10% fetal calf serum (FCS) (Sigma-406 
Aldrich) as previously described (39, 65). The HCMVs used in this study were all bacterial artificial 407 
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chromosome (BAC) clones. The clones of the endotheliotropic HCMV strain TB40/E wild-type, the 408 
revertant virus (v65Rev), and a mutant virus unable to express UL83-encoded pp65 (v65Stop) were 409 
previously generated (38). The viruses were propagated and titrated on HFFs and titrated by standard 410 
plaque assay (37, 66). HCMV infections were all performed at MOI of 1, where more than 50% of cells 411 
should be infected at 24 hpi (20, 38). 412 
Antibodies and reagents. The following primary antibodies were used: rabbit polyclonal anti-cGAS 413 
(Sigma-Aldrich), anti-Ubiquitin-K48-specific (Millipore), anti-IFI16 (Santo Landolfo) or mouse 414 
monoclonal antibodies (MAb) anti-STING (R&D), anti-pp65 (Virusys), anti-HaloTag (Promega), anti-415 
Vinculin (Sigma-Aldrich), and anti-α-Tubulin (Active-Motive). The following conjugated secondary 416 
antibodies were used: Alexa Fluor 488 anti-mouse or Alexa Fluor 568 anti-rabbit antibodies (Life 417 
Technologies) and horseradish peroxidase-labeled anti-mouse and anti-rabbit antibodies (GE 418 
Healthcare). The proteasome inhibitor MG132 (Calbiochem) was used at a concentration of 30 µM 419 
(67). Poly(dA-dT), and poly(I:C) (4 μg/mL, InvivoGen) (39, 68) were transfected into the cells using 420 
Lipofectamine 2000 according to the manufacturer’s instructions (Life Technologies).  421 
Recombinant adenoviral vectors. Adenovirus-derived vectors (AdV) expressing pp65 was generated 422 
by means of a replacement strategy using recombineering methods (69). Briefly, the UL83 ORF was 423 
amplified using specific set of primers (forward: 424 
AACCGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGG425 
GACCGATCCAGCCTGGATCCATGGAGTCGCGCGGTCGCCG, reverse: 426 
TATAGAGTATACAATAGTGACGTGGGATCCCTACGTAGAATCAAGACCTAGGAGCGGGTT427 
AGGGATTGGCTTACCAGCGCTACCTCGATGCTTTTTGGGC). In order to accomplish 428 
homologous recombination, approximately 200 ng of DNA derived from HCMV infected cells was 429 
electroporated into SW102 bacteria harboring pAdZ5-CV5 vectors. Cells were then plated on minimal 430 
medium agar plates containing 5% sucrose and chloramphenicol and incubated at 32°C for 1 day. The 431 
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colonies that appeared were inoculated into LB broth containing ampicillin and chloramphenicol and 432 
LB broth containing chloramphenicol only. In the colonies grown in chloramphenicol only, 433 
replacement of the UL83 ORF in multiple cloning sites and the ampicillin resistance were lost. 434 
Colonies were checked by PCR and sequencing. The AdVpp65 was cotransfected into HEK 293 cells. 435 
To obtain the recombinant adenoviruses, AdZ vectors were transfected into HEK 293 packaging cells. 436 
Transfected cells were maintained at 37°C with 5% CO2 until an extensive cytopathic effect was 437 
obtained. Viruses were then purified from infected cultures by freeze-thaw-vortex cycles, and assessed 438 
for pp65 expression by Western blot. For cell transduction, HFFs were washed once with phosphate-439 
buffered saline (PBS) and incubated with AdVpp65, at an MOI of 50 in DMEM. After 2 h at 37°C, the 440 
virus was washed off and fresh medium applied. For all the experiments, a recombinant adenovirus 441 
expressing the E. coli β-galactosidase gene (AdV-LacZ) was used as a control (66). 442 
Plasmid construction. The HCMV UL83 sequences were amplified using specific sets of primers 443 
(pp65 Halo-WT forward: CGGAATTCATGGAGTCGCGCGGTCG, reverse: 444 
AACTCGAGACCTCGATGCTTTTTGGGCGT; pp65 Halo-ΔC forward: 445 
CGGAATTCATGGAGTCGCGCGGTCGCC, reverse: GCTCTAGAGGTGGTTACGAGTTCTTCGT; 446 
pp65 Halo-ΔN forward: GCGAATTCATGCAGTATCGCATCCAGGGCAAG, reverse: 447 
GCTCTAGAACCTCGATGCTTTTTGGGCGT). The 5′- and 3′- primers were engineered to contain 448 
EcoRI and XbaI restriction sites. The PCR fragments were subsequently digested and directionally 449 
cloned into the corresponding sites of the pHTC HaloTag
®
 CMV-neo Vector (Promega). The following 450 
HaloTag fusion plasmids were constructed: plasmids expressing the full-length pp65 (indicated as pp65 451 
Halo-WT), the N domain (pp65 Halo-ΔC, deletion between residues 371-561), or the C domain (pp65 452 
Halo-ΔN, deletion between residues 1-414). Plasmids were then tested by Western blot and the 453 
nucleotide sequences confirmed by sequencing. HFFs were transiently transfected using a 454 
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MicroPorator (Digital Bio) according to the manufacturer’s instructions (1200 V, 30 ms pulse width, 455 
one impulse). 456 
RNA isolation and semiquantitative RT-qPCR. Total RNA was extracted using the NucleoSpin 457 
RNA kit (Macherey-Nagel) and 1 μg was retrotranscribed using the Revert-Aid H-Minus FirstStrand 458 
cDNA Synthesis Kit (Fermentas), according to the manufacturer’s protocol. Comparison of mRNA 459 
expression between samples (i.e., infected versus untreated) was performed by SYBR green-based RT-460 
qPCR using Mx3000P apparatus (Stratagene), using the following primers: IFN-β forward 461 
AAACTCATGAGCAGTCTGCA, IFN-β reverse AGGAGATCTTCAGTTTCGGAGG; the 462 
housekeeping gene Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward 463 
AGTGGGTGTCGCTGTTGAAGT, GADPH reverse AACGTGTCAGTGGTGGACCTG.  464 
Transduction of HFFs with lentiviral CRISPR/Cas9. The CRISPR/Cas9 system was employed to 465 
generate specific gene knockouts in primary human fibroblasts. Specifically, we used a lentiviral 466 
CRISPR/Cas9 vector54 that encodes a codon-optimized nuclear-localized Cas9 gene N-terminally 467 
fused to the puromycin resistance gene via a T2A ribosome-skipping sequence. Additionally, the vector 468 
contains a human U6 promoter driving expression of a guideRNA (gRNA) consisting of a gene-specific 469 
CRISPR RNA (crRNA) fused to the trans-activating crRNA (tracrRNA) and a terminator sequence.  470 
The gene-specific crRNA sequences cloned were: For IFI16 knockout 5’-471 
GTACCAACGCTTGAAGACC-3’, for cGAS knockout 5’-GACTCGGTGGGATCCATCG-3’ and for 472 
STING knockout 5’-GAGCACACTCTC CGGTACC-3’. 473 
VSVg-pseudotyped lenti-CRISPR virions were produced by transfecting HEK293T cells with the 474 
following plasmids: CRISPR/Cas9 vector, pMD.2G, pRSV-REV, and pMDlg/p-RRE. Viral 475 
supernatants were harvested after 72 h and used to transduce fibroblasts by infection in the presence of 476 
4 mg/ml polybrene. Transduced cells were selected with increasing dosage of puromycin (from 0.5 477 
µg/ml, 1 µg/ml and 2 µg/ml) over the course of 14 days post transduction. After selection the 478 
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successful knockout was confirmed using qPCR and immunoblotting. Additionally, indel frequencies 479 
were quantified using TIDE (48); genomic DNA was extracted and PCR amplicons spanning the 480 
sgRNA target site were generate. Purified PCR products were then Sanger-sequenced and Indel 481 
frequencies quantified using the TIDE software (http://tide.nki.nl). A reference sequence (WT cells) 482 
was used as a control. 483 
Immunofluorescence microscopy. Indirect immunofluorescence analysis (IIF) was performed as 484 
previously described (12) using the appropriate dilution of primary antibodies for 1 h at room 485 
temperature (RT), followed by 1 h with secondary antibodies in the dark at RT. Nuclei were 486 
counterstained with 4',6-diamidino-2-phenylindole (DAPI) or TO-PRO-3. Finally, coverslips were 487 
mounted with Vectashield mounting medium (VECTOR). Samples were observed using a fluorescence 488 
microscope (Olympus IX70) equipped with cellSens Standard - Microscopy Imaging Software, or a 489 
confocal microscope (Leica TCS SP2). ImageJ software was used for image processing. 490 
Proximity ligation assay (PLA). Proximity ligation assay (DuoLink, Sigma-Aldrich) was performed 491 
using the DuoLink PLA Kit to detect protein–protein interactions using fluorescence microscopy 492 
according to the manufacturer’s protocol. Briefly, HFFs were infected with wild-type, v65Rev or 493 
v65Stop viruses at an MOI of 1 for 2 h, fixed for 15 min at RT, permeabilized with 0.2% Triton X-100, 494 
and blocked with 10% HCMV-negative human serum for 30 minutes at RT. Cells were then incubated 495 
with primary antibodies diluted in TBS-Tween 0.05% for 1 h, washed, and then further incubated for 496 
another hour at 37°C with species-specific PLA probes under hybridization conditions and in the 497 
presence of 2 additional oligonucleotides to facilitate the hybridization only in close proximity (~40 498 
nm). A ligase was then added to join the two hybridized oligonucleotides, thus forming a closed circle. 499 
Using the ligated circle as template, rolling-circle amplification was initiated by adding an 500 
amplification solution, generating a concatemeric product extending from the oligonucleotide arm of 501 
the PLA probe. Lastly, a detection solution consisting of fluorophore-labeled oligonucleotides was 502 
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added, and the labeled oligonucleotides were hybridized to the concatemeric products. The signal was 503 
detected as distinct fluorescent dots in the Texas Red channel and analyzed by fluorescence microscopy 504 
(Olympus IX70). Negative controls consisted of mock-infected cells that were otherwise treated in the 505 
same way as described for infected cells. 506 
Western blot analysis. Whole-cell protein extracts were prepared and subject to Western blot analysis 507 
as previously described (12, 70). Briefly, an equal amount of cell extracts were fractionated by 508 
electrophoresis on sodium dodecyl sulfate polyacrylamide gels and transferred to Immobilon-P 509 
membranes (Biorad). After blocking with 5% nonfat dry milk in TBS-Tween 0.05%, membranes were 510 
incubated overnight at 4°C with the appropriate primary antibodies. Membranes were then washed and 511 
incubated for 1 h at room temperature with secondary antibodies. Proteins were detected using an 512 
enhanced chemiluminescence detection kit (SuperSignal West Pico Chemiluminescent Substrate, 513 
Thermo SCIENTIFIC). 514 
Immunoprecipitation Assay. Uninfected or HCMV-infected cells (MOI of 1) were washed with PBS 515 
and lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris pH 7.4; 150 mM NaCl; 1 mM 516 
EDTA; 1% Nonidet P-40; 0.1% SDS; 0.5% deoxycholate; protease inhibitors). Two hundred 517 
micrograms of proteins were incubated with 2 μg of specific antibody, or without antibody as negative 518 
control, for 1 h at RT with rotation followed by an overnight incubation at 4°C with protein G–519 
Sepharose (Sigma-Aldrich). Immune complexes were collected by centrifugation and washed with 520 
RIPA buffer. The Sepharose beads were pelleted and washed three times with RIPA buffer, 521 
resuspended in reducing sample buffer (50 mM Tris pH 6.8; 10% glycerol; 2% SDS; 1% 2-522 
mercaptoethanol), boiled for 5 min, and resolved on a SDS-PAGE gel to assess protein binding by 523 
Western blot. Where indicated, ∼1 U/μL Benzonase (Sigma-Aldrich) was added for 2 h on ice as 524 
described in Wu et al. (27). Immunoprecipitation of ubiquitin-conjugated proteins was performed using 525 
the UbiQapture-Q Kit (Enzo LifeScience). A total of 25 μg of lysates from cultured cells were used per 526 
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assay. Samples were added to the tubes containing 20 μL UbiQapture-Q matrix and incubated for 3h at 527 
4°C in a horizontal rotor mixer. The matrix was then carefully washed and the ubiquitin-protein 528 
conjugates were eluted by addition of 50 μL sample buffer and heating at 95°C for 10 min. The eluted 529 
fraction was clarified from the matrix and analyzed by immunoblotting. 530 
ELISA assay. The IFN-β secreted in culture supernatants was analyzed using Single Analyte Human 531 
ELISA kits for IFN-β (Human IFN Beta ELISA KIT, PBL Assay Science) according to the 532 
manufacturer’s instructions. All absorbance readings were measured at 450 nm using a Victor X4 533 
Multilabel Plate Reader (Perkin Elmer). 534 
cGAMP activity assay. cGAMP activity assay was performed as previously described (50, 52). 535 
Briefly, HFFs were infected with wild-type, v65Rev, v65Stop or transfected with poly(dA-dT) (4 536 
μg/mL) (InvivoGen) or pp65 Halo-WT using Lipofectamine 2000 according to the manufacturer’s 537 
instructions (Life Technologies). At the indicated times, cells were washed with PBS and lysed in 538 
hypotonic buffer (10 mM Tris pH 7.4; 10 mM KCl; 1.5 mM MgCl2). Cell extracts were incubated with 539 
∼1 U/μL Benzonase (Sigma-Aldrich) for 30 min at 37°C. Cell extracts were then heated at 95°C for 5 540 
min and centrifuged for 5 min at maximum speed (16,100 × g) in an Eppendorf microcentrifuge. HFFs 541 
were used as reporter cells to measure cGAMP production. HFFs were permeabilized as previously 542 
described (71) with modifications. Briefly, media was aspirated from the HFFs and digitonin 543 
permeabilization solution (50 mM Hepes pH 7.0, 100 mM KCl, 85 mM sucrose, 3 mM MgCl2, 0.2% 544 
BSA, 1 mM ATP, 0.1 mM DTT, and 10 μg/mL digitonin) was added to treated cell extracts. HFF 545 
reporter cells were incubated with extracts for 30 min at 37 °C and then replaced with supplemented 546 
media. RNA was harvested 6 h after the initial addition of extracts and RT-qPCR for IFN-β, as a 547 
marker of cGAMP activity, and GADPH, as housekeeping gene, was performed as described above.  548 
Response to exogenous cGAMP. Synthetic 2’3’-cGAMP (2 μg/mL, InvivoGen) or 2’3’-cGAMP 549 
control (2 μg/mL, InvivoGen), also known as 2’5’-GpAp, a linear dinucleotide analog after hydrolysis 550 
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of 2’3’-cGAMP by phosphodiesterases, were transfected into HFFs using Lipofectamine 2000 551 
according to the manufacturer’s instructions (Life Technologies). At the indicated time points, RNA 552 
was harvested and the IFN-β gene expression response quantified over time by RT-qPCR. 553 
Statistical analysis. All statistical tests were performed using GraphPad Prism version 5.00 for 554 
Windows (GraphPad Software, San Diego California USA, www.graphpad.com). The data were 555 
presented as means ± standard deviations (SD). For comparisons consisting of two groups, means were 556 
compared using two-tailed Student’s t-tests; for comparisons consisting of three groups, means were 557 
compared using one-way or two-way analysis of variance (ANOVA) with Bonferroni’s post-tests. 558 
Differences were considered statistically significant for P<0.05 (*, P<0.05; **, P<0.01; ***, P<0.001). 559 
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 755 
FIGURE LEGENDS 756 
FIG 1 Inhibition of IFN-β response by HCMV pp65. (A) HFFs were infected at an MOI of 1 with 757 
wild-type, v65Rev or v65Stop viruses and processed by RT-qPCR. Kinetics analysis results for IFN-β 758 
mRNA expression following HCMV- versus mock-infection were normalized to those for GAPDH 759 
expression and are shown as mean fold changes ± SD (**, P<0.01; one-way ANOVA followed by 760 
Bonferroni’s post-tests; for comparison of treated versus untreated cells). (B) HFFs were transduced 761 
with AdVLacZ (black bar) or AdVpp65 (grey bar) at an MOI of 50. Afterwards, cells were infected 762 
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with v65Stop (MOI of 1). Following a further 6 hpi, IFN-β mRNA expression was normalized to that 763 
of GAPDH and is shown as a mean ± SD fold change (**, P<0.01; unpaired t-test; for comparison of 764 
AdVpp65- versus AdVLacZ-transduced cells) (left panel). The efficiency of pp65 overexpression was 765 
analyzed by Western blot with anti-pp65 monoclonal antibody; α-Tubulin was included as a loading 766 
control. Experiments were repeated at least three times and one representative result is shown (right 767 
panel). (C) HFFs were infected with wild-type, v65Rev or v65Stop at an MOI of 1 or stimulated with 768 
poly(I:C) (4 µg/mL). Supernatants were collected at the indicated times post infection and assessed by 769 
ELISA for IFN- production. Results are shown as a mean ± SD fold change (*, P<0.05; one-way 770 
ANOVA followed by Bonferroni’s post-tests; for comparison of wild-type/v65Rev- versus 771 
v65Stop/poly(I:C)-treated cells).  772 
 773 
FIG 2 Generation of specific gene knockout cell lines by CRISPR/Cas 9-mediated genome editing. 774 
Knockout (KO) gene variants in HFFs for cGAS (cGAS KO), STING (STING KO), and IFI16 (IFI16 775 
KO), were generated using CRISPR-Cas 9 technology. The efficiency of IFI16, cGAS, and STING 776 
protein depletion was assayed by (A) RT-qPCR for cGAS, STING, IFI16, and the housekeeping gene 777 
GADPH; data are shown as mean fold changes ± SD (***, P<0.001 two-way ANOVA followed by 778 
Bonferroni’s post-tests; for comparison of KO- versus WT cells). (B) Western blot analysis for cGAS, 779 
STING, IFI16, and Vinculin, as loading control. (C-D) TIDE analysis to quantify indel frequencies and 780 
composition, by using PCR amplicons spanning the sgRNA target sites for sanger sequencing and 781 
subsequent analysis by the TIDE software (http://tide.nki.nl). 782 
 783 
FIG. 3 The cGAS/STING axis mediates IFN-β production during HCMV infection. (A) Control HFFs 784 
(WT), cGAS KO, STING KO, IFI16 KO were infected with wild-type, v65Rev or v65Stop viruses at 785 
an MOI of 1. Six hours later, IFN-β mRNA expression was processed by RT-qPCR. The values were 786 
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normalized to GAPDH mRNA and plotted as a fold induction over WT HFFs. RT-qPCR data are 787 
shown as mean fold changes ± SD (*, P<0.05; ***, P<0.001 two-way ANOVA followed by 788 
Bonferroni’s post-tests; for comparison of KO- versus WT cells). (B) HFFs WT, cGAS KO, STING 789 
KO or IFI16 KO were infected with wild-type, v65Rev or v65Stop viruses at an MOI of 1. 790 
Supernatants from the cells were collected at 24 hpi and analyzed by IFN-β ELISA. Results are shown 791 
as a mean ± SD fold change (*, P<0.05; ***, P<0.001 two-way ANOVA followed by Bonferroni’s 792 
post-tests; for comparison of KO versus WT cells). (E-F) WT, cGAS KO, STING KO, and IFI16 KO 793 
HFFs were transfected with poly(I:C). IFN-β mRNA modulation was assessed by RT-qPCR 6 hpt (C) 794 
or IFN-β ELISA assay 24 hpt (D). Results are shown as a mean ± SD fold change (***, P<0.001 two-795 
way ANOVA followed by Bonferroni’s post-tests; for comparison of poly(I:C)-transfected cells versus 796 
untransfected cells). 797 
 798 
FIG 4 HCMV pp65 inhibits cGAS activity. (A) HFFs were infected with wild-type, v65Rev or 799 
v65Stop at an MOI of 1 for 24 h. Extracts from the infected cells were prepared, DNase- and heat-800 
treated, and incubated with permeabilized HFFs for 6 h. IFN-β RNA induction was analyzed by RT-801 
qPCR and normalized to GAPDH and is shown as a mean fold change ± SD following HCMV- versus 802 
mock-infection (**, P<0.01, one-way ANOVA followed by Bonferroni’s post-test). (B) HFFs were 803 
electroporated with pp65 Halo-WT or left untransfected and then infected with v65Stop at an MOI of 1 804 
for 24 h. cGAMP was harvested at 24 hpi and assayed on HFFs. IFN-β mRNA induction was measured 805 
in HFFs at 6 hpi by RT-qPCR (***, P<0.001 one-way ANOVA followed by Bonferroni’s post-test, for 806 
comparison of v65Stop-HaloTag-transfected cells versus v65Stop-untransfected cells). (C) Cells were 807 
transduced as described in (B) and 24 h later transfected with poly(dA-dT) (4 μg/mL) for 24 h and 808 
assayed on HFFs. IFN-β mRNA induction was measured in HFFs at 6 h by RT-qPCR (***, P<0.001 809 
one-way ANOVA followed by Bonferroni’s post-test, for comparison of poly(dA-dT)- HaloTag-810 
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transfected cells versus poly(dA-dT)-untransfected cells). (D) WT, cGAS KO, STING KO, and IFI16 811 
KO HFFs were infected with wild-type, v65Rev or v65Stop at an MOI of 1. cGAMP was harvested at 812 
24 hpi and assayed on HFFs. IFN-β mRNA induction was measured in HFFs at 6 hpi by RT-qPCR 813 
(***, P<0.001; two-way ANOVA followed by Bonferroni’s post-test). (E) HFFs were transfected with 814 
synthetic 2’3’-cGAMP, 2’3’-cGAMP control (2 μg/mL), or HFFs were electroporated with pp65 Halo-815 
WT and then transfected with 2’3’-cGAMP. IFN-β mRNA induction was analyzed by RT-qPCR at the 816 
time points indicated, and normalized to GAPDH. The experiment was repeated six times and no 817 
statistically significant differences by unpaired t-test analysis were observed between cells transfected 818 
with cGAMP alone versus cGAMP plus pp65 Halo-WT. 819 
 820 
FIG 5 pp65/cGAS interaction. (A) HFFs were infected with wild-type, v65Rev or v65Stop viruses 821 
(MOI of 1) or left uninfected (mock) and subjected to IIF at 2 hpi. pp65 (green)/cGAS (red) were 822 
visualized using primary antibodies followed by secondary antibody staining in the presence of 10% 823 
HCMV-negative human serum. Nuclei were counterstained with TO-PRO-3 (blue). Images were 824 
generated by confocal microscopy; the far right hand picture shows a 3D image reconstruction using 825 
the confocal Z stacks. Digitally reconstructed 3D images were generated for at least 5 fields per 826 
condition; representative images are shown. (B) A Proximity Ligation Assay (PLA) was performed to 827 
detect protein-protein interactions using fluorescence microscopy. The signal was detected as distinct 828 
fluorescent dots in the Texas Red channel when cells reacted with the indicated pairs of primary 829 
antibodies followed by PLA to assess the interactions between pp65/cGAS. (C) Co-830 
immunoprecipitation from virus-infected or mock-infected cell lysates. HFFs were infected with wild-831 
type, v65Rev or v65Stop viruses (MOI of 1) and harvested at 2 hpi. Immunoprecipitations were 832 
performed using antibodies against pp65 or without antibody as negative control (CTRL). 833 
Immunoprecipitated proteins were detected by Western blot analyses using antibodies against pp65, 834 
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cGAS, and STING. Non-immunoprecipitated whole-cell extracts (Input) were immunoblotted using 835 
anti-pp65, anti-cGAS, and anti-STING antibodies. (D) Immunoprecipitation was performed as 836 
described in (C) except that the samples were split in two, and half were treated with benzonase (1 837 
U/μL) for 2 h on ice followed by immunoprecipitation using antibodies against pp65 (left panel). The 838 
mock cell lysate used in the IP depicted in the left panel was run onto an ethidium bromide-stained 839 
(0.8%) agarose gel. Lane 1: IP in the absence (-) of benzonase; lane 2: IP in the presence (+) of 840 
benzonase (right panel). (E) Mapping the region of pp65 required for its interaction with cGAS. Wild-841 
type pp65 (pp65 Halo-WT) and serial deletion mutants of pp65 (pp65 Halo-ΔN, pp65 Halo-ΔC) were 842 
used to immunoprecipitate lysates of HFFs transiently expressing pp65 HaloTag. Interaction was 843 
detected by Western blot analysis using antibodies against cGAS.  844 
 845 
FIG 6 STING undergoes proteasome degradation. (A) HFFs were infected with wild-type, v65Rev or 846 
v65Stop viruses at an MOI of 1. Lysates were prepared at the indicated time-points and subjected to 847 
Western blot analysis for pp65, cGAS, STING, and α-Tubulin. (B) Western blot analysis for STING in 848 
cells transfected with poly(dA-dT) (4 μg/mL) at the indicated time-points. Lysates were also stained for 849 
α-Tubulin as a loading control. (C) HFFs infected with wild-type, v65Rev and v65Stop viruses (MOI 850 
of 1) were treated with MG132 or DMSO. Cells were harvested at 6 and 24 hpi and processed for 851 
Western blot analyses with antibodies against STING. Lysates were also stained for pp65 and with α-852 
Tubulin as a loading control. (D) Co-immunoprecipitation from virus-infected or mock-infected cell 853 
lysates. HFFs were infected with wild-type, v65Rev, or v65Stop viruses (MOI of 1) and harvested at 2 854 
hpi. At the indicated time points, total cell protein extracts were immunoprecipitated for ubiquitin and 855 
stained with anti-STING antibodies. Immunoprecipitation of ubiquitin-conjugated proteins was 856 
performed using the UbiQapture-Q Kit (Enzo LifeScience). (E) Cells were infected as described in (D). 857 
Immunoprecipitations were performed using antibodies against Ubiquitin-K48-specific. 858 
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Immunoprecipitated proteins were detected by Western blot analyses using antibodies against STING. 859 
Non-immunoprecipitated whole-cell extracts (Input) were immunoblotted using anti-STING and with 860 
α-Tubulin antibodies as a loading control. 861 
 862 
FIG 7 Model depicting the proposed functional role of pp65 modulation of IFN-β activity during 863 
HCMV infection. 864 
 on F






































































ebruary 16, 2018 by U
niversity of T
orino
http://jvi.asm
.org/
D
ow
nloaded from
 
